Cellectar Seeks FDA’s OK to Advance CLR 131 into Trials for Rare Pediatric Cancers
News
Cellectar Biosciences has filed an application with the U.S. Food and Drug Administration (FDA) to advance CLR 131 into a proposed Phase 1 clinical trial testing the investigational drug in children and teenagers with rare ... Read more